Bayer AG, which acquired agri-giant Monsanto in June, posted more than 300 studies on the safety of glyphosate, the active ingredient in its widely used weed killer Roundup. The move comes four months after the company was hit with a $289 million verdict in a landmark trial brought by a school groundskeeper who alleged his exposure to the herbicide contributed to his terminal non-Hodgkin’s lymphoma diagnosis. (The award was later reduced to $78 million.) The studies were posted to mark the first anniversary of Bayer’s “Transparency Initiative,” a major PR campaign designed to “enhance trust in the science behind crop ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.